Moneycontrol
SENSEX NIFTY
you are here:

IOL Chemicals and Pharmaceuticals Ltd.

BSE: 524164 | NSE: IOLCP |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE485C01011 | SECTOR: Pharmaceuticals

BSE Live

Jul 03, 16:00
522.60 31.65 (6.45%)
Volume
AVERAGE VOLUME
5-Day
196,347
10-Day
205,546
30-Day
149,848
326,961
  • Prev. Close

    490.95

  • Open Price

    495.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jul 03, 15:57
523.00 31.75 (6.46%)
Volume
AVERAGE VOLUME
5-Day
1,715,519
10-Day
1,753,791
30-Day
1,555,380
3,557,345
  • Prev. Close

    491.25

  • Open Price

    491.55

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    523.00 (16390)

ANNOUNCEMENTS ON IOL Chemicals

  • Jun 30, 2020 17:13 Source: BSE

    IOL Chemicals and Pharmaceuticals - Closure of Trading Window

    Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s ''Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons'' the Trading Window for dealing in the securities of the Company, shall remain closed for all the designated persons and their immediate relatives from 01st July 2020 till the expiry of 48 hours after the declaration of financial results for quarter ended 30th June 2020 are made public. During the closure of Trading Window, Insiders are also advised not to deal in the shares of the Company. This is for information and record please.

  • Jun 26, 2020 12:51 Source: BSE

    IOL Chemicals and Pharmaceuticals - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd

  • Jun 25, 2020 14:48 Source: BSE

    IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Allotment

    The Allotment Committee of the Board of Directors of the Company, in its meeting held today i.e. 25th June 2020 has allotted 4,00,000 (Four Lakh) Fully Paid up Equity Shares of Rs 10/- each at a premium of Rs 195/- per share to M/s NCVI Enterprises Limited (promoter group company) upon exercise of the option attached with the Warrants allotted on 30th March 2019. The said shares shall remain locked-in for a period of 3 years from the date of trading approval. Consequent upon issue of the abovesaid 4,00,000 Equity Shares, the total paid-up capital of the Company stands increased at Rs 58,70,55,020 (Rupees Fifty Eight Crore Seventy Lakh Fifty Five Thousand Twenty Only) divided into 5,87,05,502 (Five Crore Eighty Seven Lakh Five Thousand Five Hundred Two) Fully Paid up Equity Shares of Rs 10/- each. With the conversion of the above said 4,00,000 Warrants into equity shares, now no Warrants are outstanding for conversion. The meeting was concluded at 2:30 PM

  • Jun 23, 2020 11:22 Source: BSE

    IOL Chemicals and Pharmaceuticals - Shareholding for the Period Ended June 17, 2020

    IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 17, 2020. For more details, kindly Click here

  • Jun 20, 2020 9:00 Source: BSE

    IOL Chemicals and Pharmaceuticals - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd & Others

  • Jun 17, 2020 11:41 Source: BSE

    IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Allotment

    This is to inform you that the Allotment Committee of the Board of Directors of the Company, in its meeting held today i.e. 17th June 2020 at 11:00 AM has allotted 7,18,000 (Seven Lakh Eighteen Thousand) Fully Paid up Equity Shares of Rs 10/- each at a premium of Rs 195/- per share to M/s NCVI Enterprises Limited (promoter group company) upon exercise of the option attached with the Warrants allotted on 30th March 2019. The said shares shall remain locked-in for a period of 3 years from the date of trading approval. Consequent upon issue of the abovesaid 7,18,000 Equity Shares, the total paid-up capital of the Company stands increased at Rs 58,30,55,020 (Rupees Fifty Eight Crore Thirty Lakh Fifty Five Thoudand Twenty Only) divided into 5,83,05,502 (Five Crore Eighty Three Lakh Five Thoudand Five Hundred Two) fully paid equity shares of Rs 10/- each. The meeting was concluded at 11:20 AM. This is for your information & record please.

  • Jun 15, 2020 16:14 Source: BSE

    IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to the provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies of the newspaper publication of audited financial results for the quarter and year ended 31st March 2020 published in Economic Times, Business Standard, Financial Express and Punjabi Jagran on 13th June 2020.

  • Jun 12, 2020 19:40 Source: BSE

    IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Press Release with respect to Audited Financial Results for the quarter and year ended 31st March 2020.

  • Jun 12, 2020 19:36 Source: BSE

    IOL Chemicals and Pharmaceuticals - Compliances-Reg.24(A)-Annual Secretarial Compliance

    We are enclosing herewith Annual Secretarial Compliance Report issued by M/s B.K. Gupta & Associates, Company Secretaries in compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended 31st March 2020. This is for your information & record.

  • Jun 12, 2020 19:33 Source: BSE

    IOL Chemicals and Pharmaceuticals - Disclosure Of Related Party Transactions

    Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith Disclosure of related party transactions for the year ended 31st March 2020. This is for your information & record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jun 12, 2020
Remark : Audited Results